Tiger Lily Capital, Llc - Net Worth and Insider Trading
Tiger Lily Capital, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tiger Lily Capital, Llc owns 1 companies in total, including Pasithea Therapeutics Corp (KTTA) .
Click here to see the complete history of Tiger Lily Capital, Llc’s form 4 insider trades.
Insider Ownership Summary of Tiger Lily Capital, Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KTTA | Pasithea Therapeutics Corp | 2022-10-22 | 10 percent owner |
Tiger Lily Capital, Llc Trading Performance
Tiger Lily Capital, Llc Ownership Network
Tiger Lily Capital, Llc Owned Company Details
What does Pasithea Therapeutics Corp do?
Who are the key executives at Pasithea Therapeutics Corp?
Tiger Lily Capital, Llc is the 10 percent owner of Pasithea Therapeutics Corp. Other key executives at Pasithea Therapeutics Corp include Chief Development Officer Graeme Martin Currie , 10 percent owner Paul B Manning , and 10 percent owner Bradford Manning .
Pasithea Therapeutics Corp (KTTA) Insider Trades Summary
Over the past 18 months, Tiger Lily Capital, Llc made no insider transaction in Pasithea Therapeutics Corp (KTTA). Other recent insider transactions involving Pasithea Therapeutics Corp (KTTA) include a net purchase of 30,000 shares made by Lawrence Steinman ,
In summary, during the past 3 months, insiders sold 0 shares of Pasithea Therapeutics Corp (KTTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pasithea Therapeutics Corp (KTTA) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.
Pasithea Therapeutics Corp (KTTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pasithea Therapeutics Corp Insider Transactions
Tiger Lily Capital, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Tiger Lily Capital, Llc. You might contact Tiger Lily Capital, Llc via mailing address: C/o Pbm Capital Group, Llc, 200 Garrett Street, Suite S, Charlottesville Va 22902.